LRVHealth’s Keith Figlioli on the Evolving Landscape of AI Procurement

Why It Matters

The shift toward an architecture‑first approach dictates how health systems, vendors, and investors allocate resources, determining which AI solutions achieve scale and market relevance.

Key Takeaways

• Microsoft’s Copilot suite deepens hyperscaler lock‑in for health systems.
• Foundation‑model firms aim to become orchestration middleware in healthcare IT.
• Startups must align solutions with emerging three‑layer AI architecture.
• VC funding concentrates in large rounds, fewer deals for early‑stage AI firms.
• CEOs, not just CIOs, are driving AI strategy in health organizations.

Pulse Analysis

The healthcare AI market is moving beyond isolated pilots toward a layered architecture that ties core enterprise systems, hyperscaler ecosystems, and specialized applications together. This shift mirrors broader enterprise IT trends where platforms like Microsoft’s Copilot and Google’s AI Studio become the connective tissue for data, security, and workflow. By embedding AI directly into the productivity suites that clinicians already use, hyperscalers gain unprecedented leverage, compelling health systems to consider long‑term lock‑in costs and governance implications.

At the middle tier, foundation‑model providers such as Anthropic and OpenAI are positioning themselves as the orchestration layer that can route data between record systems and niche AI agents. This nascent middleware category promises to simplify integration but also creates a new competitive frontier: who will control the “keys to the kingdom” of health‑system data? Startups targeting narrow use cases—prior authorization, revenue‑cycle automation, or ambient scribing—must now demonstrate seamless compatibility with both the underlying enterprise platforms and the emerging AI orchestration layer, or risk being sidelined.

Capital flows reflect this architectural maturation. Venture firms are gravitating toward larger, platform‑centric rounds—often $50 million or more—while early‑stage, single‑function AI ventures see fewer deals. The strategic emphasis is shifting from building standalone tools to constructing scalable, interoperable solutions that align with the three‑layer model. Health‑system CEOs, increasingly the AI champions, will need to balance innovation speed with the governance demands of security, privacy, and data provenance, shaping the next wave of AI adoption across the industry.